GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nobel Biocare Holding AG (OTCPK:NBHGF) » Definitions » Total Liabilities

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Total Liabilities : $376.5 Mil (As of Dec. 2013)


View and export this data going back to . Start your Free Trial

What is Nobel Biocare Holding AG Total Liabilities?

Nobel Biocare Holding AG's Total Liabilities for the quarter that ended in Dec. 2013 was $376.5 Mil.

Nobel Biocare Holding AG's quarterly Total Liabilities declined from Dec. 2011 ($408.88 Mil) to Dec. 2012 ($370.14 Mil) but then increased from Dec. 2012 ($370.14 Mil) to Dec. 2013 ($376.46 Mil).

Nobel Biocare Holding AG's annual Total Liabilities declined from Dec. 2011 ($408.88 Mil) to Dec. 2012 ($370.14 Mil) but then increased from Dec. 2012 ($370.14 Mil) to Dec. 2013 ($376.46 Mil).


Nobel Biocare Holding AG Total Liabilities Historical Data

The historical data trend for Nobel Biocare Holding AG's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nobel Biocare Holding AG Total Liabilities Chart

Nobel Biocare Holding AG Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 590.20 597.03 408.88 370.14 376.46

Nobel Biocare Holding AG Semi-Annual Data
Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 590.20 597.03 408.88 370.14 376.46

Nobel Biocare Holding AG Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Nobel Biocare Holding AG's Total Liabilities for the fiscal year that ended in Dec. 2013 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=188.751+(134.551+30.461
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+22.699)
=376.5

Total Liabilities=Total Assets (A: Dec. 2013 )-Total Equity (A: Dec. 2013 )
=835.514-459.052
=376.5

Nobel Biocare Holding AG's Total Liabilities for the quarter that ended in Dec. 2013 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=188.751+(134.551+30.461
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+22.699)
=376.5

Total Liabilities=Total Assets (Q: Dec. 2013 )-Total Equity (Q: Dec. 2013 )
=835.514-459.052
=376.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nobel Biocare Holding AG Total Liabilities Related Terms

Thank you for viewing the detailed overview of Nobel Biocare Holding AG's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Nobel Biocare Holding AG (Nobel Biocare Holding AG) Business Description

Traded in Other Exchanges
N/A
Address
Nobel Biocare Holding AG was founded in 2002 in Zurich,Switzerland. The Company offers dental implant systems, high-precision individualized prosthetics and CAD/CAM systems, diagnostics, treatment planning, guided surgery solutions and biomaterials. Its segments include Implant system products and Individualized products. Its geographical segments include United States, Japan, Switzerland, and Other Countries.

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Headlines